← SynDRA
LINEZOLID
SynDRA canonical compound SYN0001228 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | MAOB |
| Mechanism of action | Bacterial 50S ribosomal subunit inhibitor |
| Indication | pneumonia | skin infections |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
- Bacterial 50S ribosomal subunit inhibitor
Drug classes
- Oxazolidinone Antibacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
- Enzyme Inhibitors
- Protein Synthesis Inhibitors
ATC classes
- J01X · OTHER ANTIBACTERIALS
Cross-references
Synonyms
- linospan
- linox
- zyvox
- zyvoxid
- linezolid sodium chloride
- linezolide
- U 100766
- Linezolide
- Pnu-100766
- U-100,766
- U-100766
- Zyvox
- Linezlid
- ZLD
- Zyvoxa
- Zyvoxam
- Zyvoxid
- PNU-100766
- Linezolid & VRC3375
- Linezolid [USAN:INN]
- Zyvox (TN)
- Zyvoxam (TN)
- Zyvoxid (TN)
- NDA 21-130 Zyvox (linezolid tablets)
- NDA 21-131 Zyvox for injection (linezolid injection)
- NDA 21-132 Zyvox oral suspension (linzolid oral suspension)
- Linezolid (JAN/USAN/INN)
- PNU-100766, U-100766, Zyvoxid, Zyvoxam, Linezolid
- N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
- N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
- N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
- N-({5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide, N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
- (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
- 111GE017
- linezolid (usp monograph)
- ISQ9I6J12J
- PNU 100766
- linezolid (usp-rs)
Reported adverse events
- Headache
- Pruritus
- Lactic acidosis
- Myelosuppression
- Serotonin syndrome
- Thrombocytopenia
- Dizziness
- Eosinophilia
- Nausea
- Rash
- Stevens-Johnson syndrome
- Vertigo
Look up LINEZOLID in the interactive SynDRA portal →